Mast Cell Granule-Mediated Uptake of Low Density Lipoproteins by Macrophages: A Novel Carrier Mechanism Leading to the Formation of Foam Cells

References

• Stary H C. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989; 9: 1–19, 132
   PubMedGoogle Scholar
• Smith E B. The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lipid Res 1974; 12: 1–49
   PubMedGoogle Scholar
• Richardson P D, Davies M J, Born G V. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989; II: 941–4
   Google Scholar
• Kovanen P T. Atheroma formation: defective control in the intimal round-trip of cholesterol. Eur Heart J 1990; 11(Suppl E)238–46
   PubMedGoogle Scholar
• McGill H C, Jr. Fatty streaks in the coronary arteries and aorta. Lab Invest 1968; 18: 560–4
   PubMedGoogle Scholar
• Guyton J R, Klemp K F, Black B L, Bocan T MA. Extracellular lipid deposition in atherosclerosis. Eur Heart J 1990; 11(Suppl E)20–8
   PubMedGoogle Scholar
• Goldstein J L, Ho Y K, Basu S K, Brown M S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76: 333–7
   PubMed Web of Science ®Google Scholar
• Brown M S, Goldstein J L. Lipoprotein metabolism in the macrophage: implications for cholesterol desposition in atherosclerosis. Ann Rev Biochem 1983; 52: 223–61
   PubMed Web of Science ®Google Scholar
• Brown M S, Goldstein J L. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts. Cell 1975; 6: 306–16
   Google Scholar
• Hoff H F, O'Neil J, Pepin J M, Cole T B. Macrophage uptake of cholesterol-containing particles derived from LDL and isolated from atherosclerotic lesions. Eur Heart J 1990; 11(Suppl E)105–15
   PubMedGoogle Scholar
• Fogelman A M, Van Lenten B J, Warden C, Haberland M E, Edwards P A. Macrophage lipoprotein receptors. J Cell Sci 1988; 9(Suppl)135–49
   Google Scholar
• Khoo J C, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis 1988; 8: 348–58
   PubMedGoogle Scholar
• Hoff H F, O'Neil J, Chisolm G M, et al. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Arteriosclerosis 1989; 9: 538–49
   PubMedGoogle Scholar
• Klimov A N, Denisenko A D, Popov A V, et al. Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. Atherosclerosis 1985; 58: 1–15
   PubMed Web of Science ®Google Scholar
• O'Brien K, Chait A. Extent of aggregation of low density lipoprotein influences its mechanism of uptake by human monocyte-derived macrophages. Clin Res 1989; 37: 573A
   Google Scholar
• Steinberg D, Parthasarathy S, Carew T. E., Khoo J C, Witztum J L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–24
   PubMed Web of Science ®Google Scholar
• Pollak O J. Mast cells in the circulatory system of man. Circulation 1957; 16: 1084–9
   PubMedGoogle Scholar
• Pouchlev A, Youroukova Z, Kiprov D. A study of changes in the number of mast cells in the human arterial wall during the stages of development of atherosclerosis. J Atheroscler Res 1966; 6: 342–51
   PubMedGoogle Scholar
• Kamio A, Taguchi T, Shiraishi M, Shimata K, Takebayashi S, Cleveland J C, Kummerow F A. Mast cells in human aorta. Arterial Wall 1979; 5: 125–36
   PubMedGoogle Scholar
• Stary H C. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990; 11(Suppl E)3–19
   PubMed Web of Science ®Google Scholar
• Stary H C. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis 1987; 64: 91–108
   PubMed Web of Science ®Google Scholar
• Stehbens W E. Localization of atherosclerotic lesions in relation to haemodynamics. Atherosclerosis: biology and clinical science, A G Olsson. Churchill Livingstone, Edinburgh 1987; 175–82
   Google Scholar
• Thon I L, Uvnäs B. Degranulation and histamine release, two consecutive steps in the response of rat mast cells to compound 48/80. Acta Physiol Scand 1967; 71: 303–15
   PubMedGoogle Scholar
• Kokkonen J O, Kovanen P T. Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein. Proc Natl Acad Sci USA 1987; 84: 2287–91
   PubMed Web of Science ®Google Scholar
• Kokkonen J O. Stimulation of rat peritoneal mast cells enhances uptake of low density lipoproteins by rat peritoneal macrophages in vivo. Atherosclerosis 1989; 79: 213–23
   PubMed Web of Science ®Google Scholar
• Helander H F, Bloom G D. Quantitative analysis of mast cell structure. J Microsc 1974; 100: 315–21
   PubMed Web of Science ®Google Scholar
• Galli S J. New insights into “The riddle of the mast cells”: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Pathology Reviews, E Rubin, I Damjanov. The Humana Press Inc., Clifton 1990; 49–77
   Google Scholar
• Schwartz L B, Austen K F. Structure and function of the chemical mediators of mast cells. Prog Allergy 1984; 34: 271–321
   PubMedGoogle Scholar
• Woodbury R G, Everitt M T, Neurath H. Mast cell proteases. Methods Enzymol 1981; 80: 588–609
   PubMedGoogle Scholar
• Katz H R, Austen K F, Caterson B, Stevens R L. Secretory granules of heparin-containing rat serosal mast cells also possess highly sulfated chondroitin sulfate proteoglycans. J Biol Chem 1986; 261: 13393–6
   PubMedGoogle Scholar
• Lagunoff D, Martin T W, Read G. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol 1983; 23: 331–51
   PubMed Web of Science ®Google Scholar
• Ishizaka T, Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy 1984; 34: 188–235
   PubMedGoogle Scholar
• Röhlich P, Anderson P, Uvnäs B. Electron microscope observations on compound 48/80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules. J Cell Biol 1971; 51: 465–83
   PubMed Web of Science ®Google Scholar
• Metcalfe D D, Kaliner M, Donlon M A. The mast cell. CRC Critical reviews in immunology. CRC Press, Boca Raton 1981; 3: 23–74
   Google Scholar
• Lindstedt K A, Kokkonen J O, Kovanen P T. Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis. J Lipid Res, (in press)
   Google Scholar
• Lindahl U, Pertoft H, Seljelid R. Uptake and degradation of mast-cell granules by mouse peritoneal macrophages. Biochem J 1979; 182: 189–93
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Horisberger U, Martin U. Phagocytosis of mast cell granules by mononuclear phagocytes, neutrophils and eosinophils during anaphylaxis. IntArchs Allergy Appl Immunol 1982; 67: 219–26
   PubMedGoogle Scholar
• Kokkonen J O, Kovanen P T. Accumulation of low density lipoproteins in stimulated rat serosal mast cells during recovery from degranulation. J Lipid Res 1989; 20: 1341–8
   Google Scholar
• Dvorak A M, Schleimer R P, Schulman E S, Lichtenstein L M. Human mast cells use conservation and condensation mechanisms during recovery from degranulation. Lab Invest 1986; 54: 663–78
   PubMedGoogle Scholar
• Slutsky B, Jarvis D, Bibb P, Feldberg R S, Cochrane D E. Viability and recovery from degranulation of isolated rat peritoneal mast cells. Exp Cell Res 1987; 168: 63–78
   PubMedGoogle Scholar
• Kokkonen J O, Kovanen P T. Low density lipoprotein degradation by rat mast cells. Demonstration of extracellular proteolysis caused by mast cell granules. J Biol Chem 1985; 260: 14756–63
   PubMedGoogle Scholar
• Kokkonen J O, Kovanen P T. Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apoliproprotein B to heparin proteoglycan of exocytosed granules. Biochem J 1987; 241: 583–9
   PubMedGoogle Scholar
• Kovanen P T, Kokkonen J O. Modification of low density lipoproteins by secretory granules of rat serosal mast cells. J Biol Chem 1991; 266: 4430–6
   PubMedGoogle Scholar
• McLaren K M, Pepper D S. The immunoelectronmicroscopic localization of human platelet factor 4 in tissue mast cells. Histochem J 1983; 15: 795–800
   PubMedGoogle Scholar
• Kokkonen J O, Kovanen P T. Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro. J Biol Chem 1989; 264: 10749–55
   PubMedGoogle Scholar
• Kokkonen J O, Vartiainen M, Kovanen P T. Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A. J Biol Chem 1986; 261: 16067–72
   PubMedGoogle Scholar
• Yamamoto M, Ranganathan S, Kottke B A. Structure and function of human low density lipoproteins. Studies using proteolytic cleavage by plasma kallikrein. J Biol Chem 1985; 260: 8509–13
   PubMedGoogle Scholar
• Smith E B. Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina. Eur Heart J 1990; 11(Suppl E)72–81
   PubMedGoogle Scholar
• Hoff H F, Gaubatz J W, Gotto A M. Apo-B concentration in the normal human aorta. Biochem Biophys Res Commun 1976; 85: 1424–30
   Google Scholar
• Smith E B, Ashall C. Fibronectin distribution in human aortic intima and atherosclerotic lesions: concentration of soluble and collagenase-releasable fractions. Blochim Biophys Acta 1986; 880: 10–5
   PubMed Web of Science ®Google Scholar
• Smith E B, Keen G A, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis 1990; 10: 263–75
   PubMedGoogle Scholar
• Galli S J, Dvorak A M, Dvorak H F. Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy 1984; 34: 1–141
   PubMedGoogle Scholar
• Liu M C, Proud D, Lichtenstein L M, et al. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol 1986; 136: 2588–95
   PubMed Web of Science ®Google Scholar
• Sedgwick J D, Holt P G, Turner K J. Production of a histamine-releasing lymphokine by antigen-or mitogen-stimulated human peripheral T cells. Clin Exp Immunol 1981; 45: 409–18
   PubMed Web of Science ®Google Scholar
• Libby P, Hansson G K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991; 64: 5–15
   PubMed Web of Science ®Google Scholar
• Iverius P-H. The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. J Biol Chem 1972; 247: 2607–13
   PubMed Web of Science ®Google Scholar
• Camejo G, Rosengren B, Olson U, et al. Molecular basis of the association of arterial proteoglycans with low density lipoproteins: its effect on the structure of the lipoproteien particle. Eur Heart J 1990; 11(Suppl E)164–73
   PubMed Web of Science ®Google Scholar
• Kaminer M S, Lavker R M, Walsh L J, Whitaker D, Zweiman B, Murphy G F. Extracellular localization of human connective tissue mast cell granule contents. J Invest Dermatol 1991; 96: 857–63
   PubMedGoogle Scholar
• Dvorak A M, Schleimer R P, Schulman E S, Lichtenstein L M. Human mast cells use conversation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human lungs. Lab Invest 1986; 54: 663–78
   PubMedGoogle Scholar
• Radhakrishnamurthy B, Srinivasan S R, Vijayagopal P, Berenson G S. Arterial wall proteoglycans - biological properties related to pathogenesis of atherosclerosis. Eur Heart J 1990; 11(Suppl E)148–57
   PubMedGoogle Scholar
• Basu S K, Brown M S, Ho Y K, Goldstein J L. Degradation of low density lipoprotein dextran sulfate complexes associated with deposition of cholesteryl esters in mouse macrophages. J Biol Chem 1979; 254: 7141–6
   PubMedGoogle Scholar
• Miller J S, Schwartz L B. Human mast cell proteases and mast cell heterogeneity. Curr Opin Immunol 1989; 1: 637–42
   PubMed Web of Science ®Google Scholar
• Irani A A, Schechter N M, Craig S S, DeBlois G, Schwartz L B. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464–8
   PubMed Web of Science ®Google Scholar